Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-ɑ signaling

Xiaoli Ju,Heng Zhang,Zidi Zhou,Miao Chen,Qiang Wang

DOI: https://doi.org/10.1016/j.yexcr.2020.112315

IF: 4.145

2020-11-01

Experimental Cell Research

Abstract:<p>PD-1/PD-L1 immune checkpoint blockade therapy has been widely used for the clinical treatment of cancer. However, recent clinical trials have shown that only a small proportion of cancer patients respond to PD1/PD-L1 immunotherapy. The tumor immune microenvironment plays an important regulatory role in PD1/PD-L1 immunotherapy. Macrophages are one of the most important immune cells in the tumor immune microenvironment. In this study, we found a high correlation between macrophage infiltration and PD-L1 expression in gastric cancer (GC) specimens. Further study revealed that infiltrated macrophages released the proinflammatory cytokines TNF-ɑ and IL-6, which induced PD-L1 expression in tumor cells. The release of TNF-ɑ and IL-6 activated the NF-kB and STAT3 signaling pathway to regulate PD-L1 expression. TNF-α, p-65 and STAT3 expression in cancer patients has prognostic value in stomach adenocarcinoma. Furthermore, infiltrated macrophages can also promote GC cell proliferation by inducing PD-L1 expression in GC cells. Taken together, our results suggest that macrophages play a dual role in regulating the expression of PD-L1 in tumor cells. On the one hand, macrophages induce PD-L1 expression in tumor cells, helping tumor cells escape cytotoxic T cell killing; on the other hand, they can promote the proliferation of tumor cells by regulating the expression of PD-L1.</p>

oncology,cell biology

What problem does this paper attempt to address?

The problem this paper attempts to address is to explore how tumor-associated macrophages (TAMs) induce the expression of PD-L1 in gastric cancer cells by releasing inflammatory cytokines TNF-ɑ and IL-6, and the impact of this expression on the proliferation of gastric cancer cells. Specifically, the researchers focus on how TAMs regulate the expression of PD-L1 in the immune microenvironment of gastric cancer, which not only helps tumor cells evade the cytotoxic effects of T cells but also promotes tumor cell proliferation by regulating PD-L1 expression. Additionally, the study investigates the prognostic value of TNF-ɑ, IL-6, p-65, and STAT3 in patients with gastric adenocarcinoma.

The main findings of the paper include:
1. In gastric cancer tissue samples, macrophage infiltration is closely related to high PD-L1 expression.
2. Differentiated macrophages can induce the expression of PD-L1 in gastric cancer cells by releasing TNF-ɑ and IL-6, a process that involves the activation of NF-kB and STAT3 signaling pathways.
3. Further research indicates that macrophages promote the proliferation of gastric cancer cells by inducing PD-L1 expression.
4. The expression levels of TNF-ɑ, IL-6, p-65, and STAT3 are related to the prognosis of patients with gastric adenocarcinoma, with patients exhibiting low expression of these molecules having a better prognosis.

These findings not only deepen the understanding of the mechanisms of TAMs in the immune microenvironment of gastric cancer but also provide potential targets for developing new therapeutic strategies.